1

ICONQuarter 1, 2009 Results ended March 31, 2009

Dr. John Climax, Chairman

Mr. Peter Gray, CEO

Mr. Ciaran Murray, CFO

2

Certain statements contained herein including, without limitation,

statements containing the words “believes,” “anticipates,” “intends,”

“expects” and words of similar import, constitute forward-looking

statements concerning the Company's operations, performance,

financial condition and prospects. Because such statements involve

known and unknown risks and uncertainties, actual results may differ

materially from those expressed or implied by such forward-looking

statements. Given these uncertainties, prospective investors are

cautioned not to place undue reliance on such forward-looking

statements. The Company undertakes no obligation to publicly update

or revise any forward-looking statements, whether as a result of new

information, future events or otherwise.

Forward Looking Statement

3

$201.3m$219.8m

Q1 2008 Q1 2009

Quarterly Net Revenue Growth

4

$21.5m

$26.9m

Q1 2008 Q1 2009

Quarterly Operating Income

5

10.7%11.2%

12.0% 12.0% 12.2%

Q1 2008 Q2 2008 Q3 2008 Q4 2008 Q1 2009

Operating Margins(After charging non-cash stock compensation expense (SFAS123R))

6

11.0%11.5%

12.5% 12.3% 12.5%

Q1 2008 Q2 2008 Q3 2008 Q4 2008 Q1 2009

Quarterly Clinical Core Operating Margin

7

Quarterly Central Laboratory Operating Margin

7.5% 7.8% 7.1%8.8% 9.4%

Q1 2008 Q2 2008 Q3 2008 Q4 2008 Q1 2009

8

35c

28c

Q1 2008 Q1 2009

$20.9m

$16.9m

Quarterly Earnings per Share and Net Income

9

Quarter ended

Mar 31, 2009

Year ended

Dec 31, 2008

Cash from operating

activities 24.7 81.3

Capital Expenditure 8.1 67.9

Net Debt (2.2) (4.3)

Net Accounts Receivable 210.3 230.3

DSOs 59 Days 69 Days

Balance Sheet$ million

10

Outlook

11

Business Wins

$394m

$440m

$393m

$296m

$321m

$369m

$337m$350m

$261m$265m

Q1 2008 Q2 2008 Q3 2008 Q4 2008 Q1 2009

Gross Awards

Net Awards

1.21.2

1.6

1.8

1.5

Book to Bill

12

$1,784m$1,748m$1,736m$1,633m$1,486m

Q1 2008 Q2 2008 Q3 2008 Q4 2008 Q1 2009

Total Backlog

13

$673m$707m

$763m$752m

$690m

Q1 2008 Q2 2008 Q3 2008 Q4 2008 Q1 2009

77%76%77%

74%71%

Backlog forecast to be earned in the next12 months (US$ & % of total forecasts)

14

Questions &

Answers

Dr John Climax, Chairman

Mr Peter Gray, CEO

Mr Ciaran Murray, CFO

15

Q1 net revenues ↑ 9%

Q1 income from operations ↑ 25%

Q1 Operating margin of 12.2%

Q1 EPS ↑ 25%

Book-to-bill ratio 1.2 Acquired a 100 bed Phase I unit in Omaha,

Nebraska

Summary Quarter 1, 2008